KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $26,000 | -7.1% | 7,574 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | -9.7% | 7,574 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | -11.4% | 7,574 | 0.0% | 0.00% | – |
| Q4 2017 | $35,000 | +52.2% | 7,574 | +130.6% | 0.00% | – |
| Q3 2017 | $23,000 | -4.2% | 3,285 | 0.0% | 0.00% | – |
| Q2 2017 | $24,000 | +20.0% | 3,285 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | +5.3% | 3,285 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | +11.8% | 3,285 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | -22.7% | 3,285 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +46.7% | 3,285 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -11.8% | 3,285 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | +325.0% | 3,285 | +168.8% | 0.00% | – |
| Q3 2015 | $4,000 | 0.0% | 1,222 | +175.2% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 444 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | – | 444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |